TP53 and cancer: In addition, recent reports have shown that an apoptin-producing recombinant VV selectively kills human cancer cells in vitro and in vivo31, and that VV expressing p53 effectively infects glioma cells and induces apoptosis32, suggesting that the recombinant “armed” OVV can be designed to express additional therapeutic genes that enhance the efficiency of destruction of the cancer cells.